The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world data on bispecific antibodies (BsAbs) administration in community oncology settings.
 
Brian Mulherin
Employment - American Oncology Network
Leadership - American Oncology Network
Stock and Other Ownership Interests - American Oncology Network
Honoraria - Alexion Pharmaceuticals; Apellis Pharmaceuticals; Caris Life Sciences; CTI BioPharma Corp; Daiichi Sankyo/Lilly; Incyte; Janssen Oncology; Janssen Oncology; Kite/Gilead; Novartis; Swedish Orphan Biovitrum; TG Therapeutics
Consulting or Advisory Role - Apellis Pharmaceuticals; BeiGene; Novartis; Pharmacosmos; Vertex
Speakers' Bureau - Apellis Pharmaceuticals
Research Funding - Apellis Pharmaceuticals; Novartis (Inst); Pharmacyclics/Janssen
Travel, Accommodations, Expenses - Apellis Pharmaceuticals; Incyte; Kite, a Gilead company
 
Brett Blum
Employment - Flatiron Health; Miba (Meaningful Insights Biotech Analytics)
 
Jim Chen
Employment - MiBA- Meaningful Insights Biotech Analytics
 
Toni Perry
Employment - MiBA- Meaningful Insights Biotech Analytics
 
Renee Pearl
Employment - MiBA- Meaningful Insights Biotech Analytics
 
Melody Chang
No Relationships to Disclose
 
Scott Newman
Employment - MiBA- Meaningful Insights Biotech Analytics
Stock and Other Ownership Interests - GeneDx/BioReference
 
Ruemu Birhiray
Employment - Hematology Oncology of Indiana
Consulting or Advisory Role - Abbvie; Array BioPharma; Coherus Biosciences; Epizyme; Exelixis; Genentech; Ipsen; Janssen; Janssen Scientific Affairs; Lilly; Regeneron; Sanofi; Taiho Pharmaceutical; Takeda; TG Therapeutics
Speakers' Bureau - Abbvie; Amgen; Astellas Pharma; AstraZeneca; BeiGene; Blueprint Medicines; Bristol-Myers Squibb; Coherus Biosciences; Daiichi Sankyo; Dova Pharmaceuticals; Exelixis; Genzyme; GlaxoSmithKline; Incyte; Janssen Oncology; Lilly; Pfizer; Pharmacyclics; Puma Biotechnology; Regeneron; Sanofi; SERVIER; Stemline Therapeutics; Taiho Pharmaceutical
Research Funding - Genentech; Regeneron; Takeda